Mediclinic Precise is part of Mediclinic International, one of the world’s leading private healthcare companies with operations in Southern Africa, the United Arab Emirates and Switzerland.
At Mediclinic Middle East, we are using state-of-the-art technology as part of our Mediclinic Precise programme to transform healthcare delivery in the region, by interpreting genetic information to create personalised prevention and treatment plans for our patients. Our goal is to deliver effective, innovative and high-quality precision medicine services at an affordable price, with the purpose of enhancing the lives of the UAE community.
At Mediclinic Precise, we believe every patient is unique, and that every patient’s health management plan should be too. Through genomic testing we can target treatment to you and your DNA, by taking into account your risk for certain genetic conditions, understanding how well you respond to certain medications and dosage, and leading to a better quality of life.
All genetic testing is carried out using the very latest sequencing technology at our specially commissioned precision medicine laboratory at Mediclinic City Hospital in Dubai. Our multidisciplinary team of medical doctors, scientists, genetic counsellors and molecular geneticists offers support to healthcare professionals and their patients affected by or at risk of suffering from a genetic disease.
Mediclinic Precise can work directly with patients and also give guidance and support to healthcare professionals who may not be specialists in this area, enabling them to use of the capabilities of these emerging technologies to personalise the management of genetic disorders, cancers and other complex multifactorial disorders to the advantage of their patients.